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The Pan American Health Organization
(PAHO) was born in 1902 out of concern for the
spread of infectious diseases. The outbreak of
cholera in Hamburg in 1892 and the epidemics of
yellow fever in the Americas led to the decision to
establish the International Sanitary Bureau with
permanent headquarters in Washington. At the
conference that made this historic decision in 1902,
participating countries agreed to cooperate with
each other and transmit to the bureau “all data of
every character relative to the sanitary conditions
of their ports and territories and furnish said
Bureau every opportunity and aid for a thorough
and careful study and investigation of any
outbreaks of pestilential disease.” All this was to be
done to provide the “widest possible protection of
the public health of each of the said republics and
that commerce between said republics may be
facilitated.”
To a very large extent, we are still following the
bureau’s recommendations, only the list of
pestilential diseases is shorter by one. Smallpox is
no longer with us—and cholera, yellow fever, and
bubonic plague are now among the emerging
diseases. Cholera is far from disappearing. There
were approximately 400,000 cases in the Americas
in 1991. This number fell to 18,000 in 1997, but
recent reports indicate that as a result of flooding
caused by El Niño, the number of cases in Peru has
increased dramatically this year. For the first 4
weeks of this year, 2,863 cases were reported
compared with 174 for the same period last year
and 3,500 for the whole of 1997.
Over the past 5 years, emerging diseases have
caused intense concern and activity. The growth
in international travel is a major factor. Statistics
from the World Tourism Organization show that
some 1 million persons per day traveled from
their homes by air in 1995. International travel
has increased every one of the past 10 years with
an average increase of 5.5% per annum.
Approximately 1.6 million people cross or recross
the U.S.-Mexico border every day by land.
Cholera did not spread between the Peruvian
towns of Chancay and Chimbote by air travel, but
by normal intercity traffic.
The spread of antibiotic resistance is another
reason for the emergence of disease; the
indiscriminate use of antibiotics is to blame. In the
South, antibiotic abuse is facilitated by ready
availability without a prescription. In some
countries, local pharmacies stock and dispense
antibiotics with the same facility as they do cough
syrups. In one study of private pharmacies, 42% of
the antibiotics were dispensed without prescription
(1); in another study, only 23% were given with a
physician’s prescription (2).
The essential elements of a control strategy for
addressing emerging infections are a surveillance
system, strengthening the public health infrastruc-
ture (including enhancing laboratory capability),
stimulation of research, and training of personnel.
This strategy is difficult. However, a review of past
surveillance activities provides specific lessons.
At the regional level, three disease surveillance
systems (for foot-and-mouth disease, poliomyelitis,
and measles) have worked and are working. An
essential common feature is that surveillance leads
to definitive action. For example, detection of cases
of poliomyelitis (before the disease was finally
eliminated from the Americas) automatically
triggered a response. The report of a suspected
case now causes resources to be mobilized to
establish the validity of the report.
In addition, strong motivation undergirds
surveillance. In the case of animal vesicular
disease, there is the intense commercial interest
behind the maintenance of the system and the
possibility of eradication of foot-and-mouth disease.
The commercial interest arises because elimina-
tion of the disease from the countries of the South
represents a possibility of exporting beef worth
billions of dollars. Interest rests not only with the
national authorities; small communities actually
drive the system. An estimated 70% of the cattle are
owned by peasants, who each own 10 or fewer.
Systematic regular feedback is necessary to
maintain interest.
The surveillance systems for these diseases are
based on the use of geographic coordinates to
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divide the countries into grids that represent the
special unit in which the data are collected.
Reports are sent by the local veterinary service to
the Pan American Foot-and-Mouth Disease
Center in Brazil. In recent years, a system has
been developed for childhood illnesses that is as
sensitive as that which reports animal diseases.
The driving force behind the successful
development and maintenance of the surveillance
system for these childhood illnesses is the
possibility of a finite end—eradication and the
emotional pride that national health workers and
politicians have in reaching this end.
Perhaps the most important aspect of
successful surveillance systems is the presence of a
credible coordinating international body. No
effective international surveillance system can be
mounted by a single country, no matter how well it
is endowed. External energy, commitment, exper-
tise, and persistence are necessary for such systems
to function.
The technology of communication should not
become the focus of our efforts. The surveillance
and containment systems for smallpox depended on
telegrams, telexes, and, I suspect, talking drums.
“In India, the largest of the endemic countries,
there were no fewer than 8,167 units reporting
weekly to 397 district offices, which in turn reported
to 31 state program offices and those to the national
program office in New Delhi” (3). All this and more
was sent to Geneva to be analyzed and reported
back faithfully, without the benefit of electronic
mail. New information technology is not an
indispensable part of the solution.
It is challenging to our sense of superiority as a
species to realize that diseases will always emerge.
Changes in our social and physical ecology will
almost certainly ensure the emergence of new or old
diseases, and we are now more vulnerable to these
diseases than before. Thus, strategies and policies
must be able to be adapted to confront the inevitable
new threats; the international community must
avoid the peaks and valleys of action that
accompany public interest in the exotic.
We have already begun to implement agreed-
upon strategies in one particular area. To establish
a system for surveillance of antibiotic resistance to
enteric pathogens, we identified participating
laboratories in 14 countries of the Americas. The
next step was to standardize isolation techniques
and review methods for measuring antibiotic
sensitivity. We are applying an approach similar to
the one that proved successful with the Pan
American Regional Poliomyelitis Laboratory Net-
work and have adopted “open regionalism”—
establishing limited networks that may expand
eventually and cooperate among themselves.
PAHO is also creating a functional network of
laboratories in the greater Amazon Region to
provide data on emerging infections. The partici-
pating laboratories’ common objective will be the
provision of accurate results, prompt sharing of
information and research protocols, and a
mechanism for rapid transfer of technology.
However, the laboratories will need external
support to sustain the system.
A strong global system for the application of
strategies to control emerging diseases will not
occur if the agreement on global action exists only in
the sphere of surveillance. There is a fundamental
need for other health professionals, in addition to
microbiologists, to be convinced of the need for a
global approach to some health issues.
The fear of infectious disease has been a
powerful stimulus for global action. The successful
global system for influenza is due partly to the
coordinating efforts of the World Health Organiza-
tion (WHO) and the work of the key collaborating
laboratory centers. Involvement in these efforts
keeps laboratories abreast of the latest develop-
ments in their special fields.
The need for global health coordination has
been very much in the news; the appropriate body
to perform that function is WHO. Most nations
agree that they must assume responsibility for
what are called essential public goods, e.g.,
immunization, provision of clean water. But some
goods are public beyond national considerations,
and no single nation can coordinate the availability
of these international public goods.
International leadership goes beyond emerging
diseases; indeed the success of a global effort to
address the threat of these diseases depends largely
on the wider perception of responsibilities for global
coordination in health. Some believe that the global
effort must focus on problems more common in the
developing world and that global coordination is a
mechanism for channeling resources from the rich
to the less fortunate. However, all countries need to
appreciate the benefits of global coordination of
efforts such as those needed to address emerging
diseases. Multilateralism is not antithetical to
national interests or bilateral approaches. Success
of this multilateral approach will require budgetary
support. The annual regular budget of WHO is
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budget. As Joshua Lederberg said, “Our thinking has
been impoverished in terms of budget allocation for
dealing with health on an international basis.”
Some very successful efforts at global
coordination in health have been disease or theme
specific, and the “Special Program” approach has
given some very good results. However, we should
go beyond that and have a global health forum or
council in which those agencies and institutions
active or becoming increasingly active in health join
with WHO in determining how to coordinate the
various efforts. I would include in this forum
representation from the multilateral financial
institutions, the private sector, and nongovernmen-
tal organizations. Different spheres of interest and
action would complement each other, which should
help correct the current ad hoc theme-driven
approach that continues to draw criticism.
PAHO has emphasized the benefit of a
collective approach, and Panamericanism is one of
the major underlying principles of the organization’s
work. For example, “Health Technology Linking
the Americas,” a concept that promotes the
availability of simple effective technologies through-
out the Americas, is a current initiative. Vaccines
are one of the technologies emphasized.
In conclusion, we must promote the individual
study of the nature and local means of control of
emerging diseases. However, we also need a more
collective approach at the regional, or even better,
the global level—this approach is bound up with the
support for global action on other fronts in health.
The most powerful instrument we have is
multipronged advocacy—advocacy is needed at the
political and popular levels for this approach. The
public must be engaged on a more regular basis to
consider the truism that public health must be a
concern of the public. This advocacy has to use some
specific examples of those matters that affect the
public’s health so that emerging diseases are not
seen as a threat only on television.
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